A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Rescinnamine
Letermovir
The metabolism of Panobinostat can be decreased when combined with Letermovir.
Rescinnamine
Dacomitinib
The metabolism of Panobinostat can be decreased when combined with Dacomitinib.
Rescinnamine
Benzyl alcohol
The metabolism of Panobinostat can be decreased when combined with Benzyl alcohol.
Rescinnamine
Tesmilifene
The metabolism of Panobinostat can be decreased when combined with Tesmilifene.
Rescinnamine
Yohimbine
The metabolism of Panobinostat can be decreased when combined with Yohimbine.
Rescinnamine
Triclabendazole
The metabolism of Panobinostat can be decreased when combined with Triclabendazole.
Rescinnamine
Indenolol
The metabolism of Panobinostat can be decreased when combined with Indenolol.
Rescinnamine
Solifenacin
The metabolism of Panobinostat can be decreased when combined with Solifenacin.
Rescinnamine
Dexchlorpheniramine
The metabolism of Dexchlorpheniramine can be decreased when combined with Panobinostat.
Rescinnamine
Deutetrabenazine
The metabolism of Deutetrabenazine can be decreased when combined with Panobinostat.
Rescinnamine
Iloperidone
The metabolism of Iloperidone can be decreased when combined with Panobinostat.
Rescinnamine
Tetrabenazine
The metabolism of Tetrabenazine can be decreased when combined with Panobinostat.
Rescinnamine
Zuclopenthixol
The metabolism of Zuclopenthixol can be decreased when combined with Panobinostat.
Rescinnamine
Ponatinib
The metabolism of Ponatinib can be decreased when combined with Panobinostat.
Rescinnamine
Trabectedin
The metabolism of Panobinostat can be decreased when combined with Trabectedin.
Rescinnamine
Ciclesonide
The metabolism of Panobinostat can be decreased when combined with Ciclesonide.
Rescinnamine
Relugolix
The risk or severity of QTc prolongation can be increased when Relugolix is combined with Panobinostat.
Rescinnamine
Fostemsavir
The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Panobinostat.
Rescinnamine
Gallopamil
The risk or severity of QTc prolongation can be increased when Gallopamil is combined with Panobinostat.
Rescinnamine
Lurasidone
The risk or severity of QTc prolongation can be increased when Lurasidone is combined with Panobinostat.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3